Safety, Acceptance and Metabolic Effects in Infants Receiving a Novel Low Glycaemic Index follow-on Formula
Study Details
Study Description
Brief Summary
In this study, the safety, acceptance and metabolic effects in infants receiving a novel low glycaemic index follow-on formula will be investigated.
After 4 week intervention period, metabolic response after feeding is significantly different between a follow-on formula containing low glycaemic carbohydrate and a conventional follow-on formula containing higher glycaemic carbohydrates.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Modified infant follow-on formula Infants are fed a modified infant follow-on formula (modified carbohydrate composition) for 4 weeks, according to protocol |
Other: Modified infant follow-on formula
The modified infant follow-on formula has a different carbohydrate pattern than the standard formula
|
Active Comparator: Standard infant follow-on formula Infants are fed a commercial follow-on formula for 4 weeks, according to protocol |
Other: Standard infant follow-on formula
Infants are fed a commercial follow-on formula
|
Outcome Measures
Primary Outcome Measures
- metabolic response [After 4 week intervention period]
After 4 week intervention period, metabolic response after feeding is significantly different between a follow-on formula containing low glycaemic carbohydrate and a conventional follow-on formula containing higher glycaemic carbohydrates.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
generally healthy infants born
-
weight between 10th and 90th percentile for age, according to the EURO Growth guidelines
-
age between 5 - 7th month of life at study entry
-
fully formula fed for at least 4 weeks before intervention start
-
parents/caregivers understand the German language and are able to fill out questionnaires
-
parents/caregivers agree to study participation and sign the informed consent form
Exclusion Criteria:
-
acute or chronic illness of infant or mother
-
drug and/or alcohol abuses of mother
-
chronic medication
-
participation of the infant in another intervention study
-
gestational diabetes of the mother
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Germany, Hauner Childrens Hospital, Ludwig-Maximilians - University of Munich | Munich | Germany | 80337 |
Sponsors and Collaborators
- Ludwig-Maximilians - University of Munich
- Beneo GmbH
Investigators
- Study Director: Berthold Koletzko, Prof., Germany, Hauner Childrens Hospital, Ludwig-Maximilians - University of Munich
- Principal Investigator: Berthold Koletzko, Prof., Germany, Hauner Childrens Hospital, Ludwig-Maximilians - University of Munich
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 114-12